Navigation Links
Amedisys to Present at 2007 BMO Capital Markets Focus on Healthcare Conference in New York
Date:11/28/2007

BATON ROUGE, La., Nov. 28 /PRNewswire-FirstCall/ -- Amedisys, Inc. (Nasdaq: "AMED" or the "Company"), one of America's leading home health nursing companies, today announced that Larry R. Graham, President and Chief Operating Officer, and Dale E. Redman, Chief Financial Officer, will present at the 2007 BMO Capital Markets Focus on Healthcare Conference in New York on Tuesday, December 4, 2007.

The presentation will begin at 2:30 p.m. Eastern time. The audio presentation will be webcast live and will be available at the following web address:

http://www.bmocm.com/conferences/2007healthcare/

Amedisys, Inc. is headquartered in Baton Rouge, Louisiana. Its common stock trades on the Nasdaq Global Select Market under the symbol "AMED".

This press release includes statements that may constitute "forward- looking" statements, usually containing the words "believe", "estimate", "project", "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's services in the marketplace, competitive factors, changes in government reimbursement procedures, dependence upon third-party vendors, and other risks discussed in the Company's periodic filings with the Securities and Exchange Commission. By making these forward- looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

Additional information on the Company can be found at: http://www.amedisys.com

Contact: Amedisys, Inc. Amedisys, Inc.

Director of Investor Relations Senior V
'/>"/>

SOURCE Amedisys, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Amedisys to Host Conference Call to Discuss Third Quarter Financial Performance and Operating Results
2. Amedisys Reports Record Third Quarter Revenue and Earnings
3. Amedisys to Present at 2007 CIBC Healthcare Conference in New York
4. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
5. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
6. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
7. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
8. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
9. AtriCure to Present at Roth Capital Partners 2007 New York Conference
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. MDS to Present at Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...clinical trial results could lead to availability ...reatment for deep lines and wrinkles by 2009. , ...y 24, 2008 -- Gel-Del Technologies , a St. Paul, ...d that it has concluded clinical trials of Cosmeta...ials say holds potential to be a more effective al...
(Date:7/23/2008)... the Financing Needs of European and A... YORK, July 24 /PRNewswire/ -- Paul Capital Partne...en promoted to Partner. Based in Paul,Capital,s Lo...ng,evaluating and negotiating European and Asian ...apital Healthcare funds., "Since he joined Paul C...
(Date:7/23/2008)...out-of-state intended parents, SAN RAMON, Calif.,...reme Court decision to allow gay couples to marry ...ence Center of the Bay Area (RSC), one of,the stat...nd lesbians for,infertility treatment., "Californ...C,s,long-held views that procreation is a natural ...
(Date:7/23/2008)...Call/ -- The Hanover Insurance Group,a leading su...announced it,is prepared to respond to claims resu...ugh southern Texas today., (Logo: http://www.new... are deeply concerned about individuals and busine...ent of The Hanover,s Central Region. "Our,staff is...
Breaking Medicine News(10 mins):Health News:Clinical Trial Concluded For New Wrinkle Treatment 2Health News:Clinical Trial Concluded For New Wrinkle Treatment 3Health News:Paul Capital Partners Promotes Ken Macleod To Partner 2Health News:Paul Capital Partners Promotes Ken Macleod To Partner 3Health News:California Supreme Court Gay-Marriage Ruling Reinforces Top Bay Area Fertility Specialists' Support for Same-Sex Couples 2Health News:The Hanover Ready to Serve Policyholders Impacted by Hurricane Dolly 2
...der women suffering from chronic cytomegalovirus//...in life) were found to have more than triple the r... infection. This was reported in the Journal of th...time an association between CMV and frailty syndro...
...echnique to increase blood flow to the heart// tha...o increase 5 years of patients’ life than the coro...dical Center, US, have found that patients who had...eries have more life span when they undergo arteri...
...s with the help of seroquel is effective//, says a...bling mental illness. Some of the symptoms suffere...d, feelings of being persecuted, becoming withdraw...a can be treated symptomatically, but only one in ...
...od lower risk// of stroke.This link between childh... in a very interesting study published in the jour...n adults is not just due to exposure to risk facto...lated event over an entire lifetime. Previous stud...
Other Medicine News:Health News:Association between childhood diet and stroke 2
(Date:7/23/2008)...uly 23 /- Sound Pharmaceuticals (SPI)... with the FDA for the clinical,testing of a propri...,chemotherapy induced hearing loss or ototoxicity....ll be tested in advanced stage lung cancer,and hea...d chemotherapy.,This marks the second development ...
(Date:7/23/2008)...SCO, July 23 /- InCode BioPharmaceuti...oday announced preclinical test,results demonstrat... for,the treatment of the rare chronic blood disor... complete results will be presented at the XXII,In...and, September 28,2008., The only treatment curr...
(Date:7/22/2008)...fficacy results from a multi-center 293-patient Eu...onto Stock Exchange Symbol: CYT, MONTREAL, July 2...s,Inc., the global leader in cryotherapy products ... results previously presented from three,European ...ctic Front(R),were published earlier today in the...
(Date:7/22/2008)...strates Feasibility and Efficacy of Treating Patie...ncer, SAN FRANCISCO, and YONGIN-SI, South Korea, ...sco, CA and Ottawa, Ontario), and its South,Korean...ovel findings from,a Phase I clinical trial of its...hat the product was well-tolerated and resulted in...
Breaking Medicine Technology:Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4APHA Says Investing in Healthy People and Communities Can Help Create a Healthy Economy 10240 1APHA Says Investing in Healthy People and Communities Can Help Create a Healthy Economy 10240 2Cellix Ltd Launches the First Semi Automated High Throughput Cell Adhesion Assay Platform 2770 1Cellix Ltd Launches the First Semi Automated High Throughput Cell Adhesion Assay Platform 2770 2New study finds resistant organisms at core of soft contact lens corneal infections 10235 1New study finds resistant organisms at core of soft contact lens corneal infections 10235 2Alexion Pharmaceuticals Invites You to Participate in its Fourth Quarter and Full Year 2007 Results Conference Call and Web Cast 2766 1
...ne, the U.S.-based subsidiary of,Pharmexa A/S, pre...gram today at the Influenza Conference entitled, "...Toronto, Ontario, Canada. The,data show that a "un...immune responses can protect transgenic mice again..., HORSOLM, Denmark, June 21, 2007-Pharmexa-Epimmun...
... June 21, 2007 - “In anaplastic,astrocytoma,...erior,to temozolomide,” Prof. Albert Wong, M...nted on the international Phase,IIb study with the...by Antisense Pharma. Prof. Wong discussed the resu...on central nervous system tumors,at the 43rd Annua...
Other Medicine Technology:Pharmexa A/S (DK) - Pharmexa presents data from influenza program 2Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 2Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 3Antisense Pharma: Promising Phase IIb Results of Targeted Therapy,with AP 12009 in Recurrent Anaplastic Astrocytoma 4
...es, the Advantage Smart Table goes up to 6 inches ...h to accommodate all open procedures. Controlled w...sitions for various surgeons and procedures. One b...to level. The simple unidirectional set-up of the ...
Inquire
Liquichek Elevated CRP Control is a liquid assayed serum control with elevated levels of C-Reactive Protein.
Liquichek Cardiac Markers Plus Control is a premium, comprehensive cardiac assessment control with many analytes and long stability.
Medicine Products: